Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metart 50mg/12.5mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Precise Lifescience

Salt Composition

Metoprolol Succinate (50mg) + Chlorthalidone (12.5mg)

Overview Metart 50mg/12.5mg Tablet ER

Cardiovasc 50mg/12.5mg Extended-Release Tablets manage hypertension (high blood pressure) when other treatments prove insufficient. This medication aids in blood pressure regulation, lowering the risk of future strokes and heart attacks. Prompt administration improves survival rates following a heart attack. Take Cardiovasc 50mg/12.5mg ER tablets once daily, preferably in the morning, with or without food, to minimize nighttime urination. Continue treatment as directed by your physician; cessation, even with symptom improvement, can worsen your condition as hypertension often presents asymptomatically. Lifestyle modifications, including regular exercise, weight management, and a healthy diet, complement this therapy. Follow your doctor's instructions carefully. Common side effects include nausea, constipation, diarrhea, and fatigue. Report any persistent, worsening, or bothersome side effects to your physician. Increased fluid intake can alleviate muscle weakness, dry mouth, and excessive thirst. Initial dizziness or headache, potentially caused by lower blood pressure, usually subsides. Inform your doctor of pre-existing liver or kidney conditions, or if you are pregnant or breastfeeding. Disclose all current medications, particularly those for hypertension or heart problems. Regular monitoring of blood pressure, kidney function, blood sugar, and electrolyte levels (potassium and magnesium) is crucial to assess treatment effectiveness.

Uses of Metart 50mg/12.5mg Tablet ER

Elevated blood pressure

Major Benefits of Metart 50mg/12.5mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metart 50mg/12.5mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. While consumption with or without food is acceptable, consistent timing is recommended.

Common Side effects of Metart 50mg/12.5mg Tablet ER:

  • Nausea
  • Constipation
  • Diarrhea
  • Fatigue
  • Headache
  • Dizziness
  • Slow heart rate
  • Increased blood uric acid
  • Decreased potassium level in blood
  • Glucose intolerance
  • Altered blood lipid level
  • Cold extremities
  • Decreased magnesium level in blood
  • Increased calcium level in blood

How to use Metart 50mg/12.5mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 50mg/12.5mg Metart Extended-Release tablet whole; avoid chewing, crushing, or breaking it. While you may consume it with or without food, consistent timing is recommended.

How Metart 50mg/12.5mg Tablet ER works:

Metart 50mg/12.5mg Extended-Release tablets combine metoprolol succinate, a beta-blocker, and chlorthalidone, a diuretic, to manage hypertension. Metoprolol succinate acts on the heart, decreasing heart rate and improving its pumping efficiency. Chlorthalidone reduces blood pressure by promoting fluid and electrolyte excretion, leading to vasodilation and enhanced circulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Metart 50mg/12.5mg Extended-Release tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Metart 50mg/12.5mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Metart 50mg/12.5mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Taking Metart 50mg/12.5mg Extended-Release tablets might reduce awareness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Exercise caution when prescribing Metart 50mg/12.5mg Extended-Release tablets to individuals with severe renal impairment; dosage modification may be necessary. Physician consultation is advised. This medication is contraindicated in patients with severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Metart 50mg/12.5mg Extended-Release Tablets cautiously; dosage modification may be necessary. Severe hepatic dysfunction contraindicates the use of Metart 50mg/12.5mg Extended-Release Tablets; consult a physician.

What if you forget to take Metart 50mg/12.5mg Tablet ER :

Should you forget to take a Metart 50mg/12.5mg Extended-Release tablet, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metart 50mg/12.5mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Heart
Metart 50mg/12.5mg Tablet...
83
MRP 101
17% off